Some Considerations for the Use of the Abbreviated Profile of Hearing Aid Benefit (APHAB) as a Hearing-Aid Outcome Measure.
Larry E Humes, Sumitrajit Dhar, Jasleen Singh
PMID 40692325WHAT IT FOUND
Hearing aid benefit scores depend heavily on how much trouble a person had before fitting.
A single pass-fail score misses this. Clinicians should judge improvement relative to the patient's own baseline difficulty, not against a fixed group average.
Key findings
01The amount of benefit reported on the APHAB-global scale is strongly predicted by the patient's unaided baseline score, with benefit typically representing about 55% to 67% of the baseline difficulty level.
02Applying a single fixed minimum detectable difference (19%) to all patients identified meaningful benefit in only 41.2% of a hearing aid trial sample, whereas using baseline-specific thresholds identified benefit in 84.9%, a figure that matched the actual device retention rate.
03The authors recommend using a half-step change on the seven-point response scale as the minimum clinically important difference, calculated by averaging the integer response ratings rather than converting them to percentages.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study relies on self-reported frequency of difficulties, which does not directly measure speech understanding ability. The recommended half-step change criterion is based on the authors' analysis and has not been widely used in previous research, so it lacks external validation. The data includes a large proportion of patients with mild-to-moderate hearing loss, so the findings may not apply to those with very severe or very mild losses. Regression to the mean was considered but could not be fully ruled out as a contributor to the observed patterns.
Declared interests
The NU data was funded in part by a Patient-Centered Outcomes Research Institute (PCORI) Award. The authors declared no potential conflicts of interest.
The easy way to misread this
Do not assume that a large percentage-point improvement in the APHAB score means the patient's speech understanding has improved. The APHAB measures how often difficulties occur, not how hard it is to understand speech. A patient might experience difficulties less often but still struggle significantly when they do occur.